Edward Lee Carter։ Stroke Prevention Starts in the Emergency Department – but Doesn’t End There
Edward Lee Carter, Clinical Pharmacist Practitioner at U.S. Department of Veterans Affairs, shared Emergency Medicine News’s post on LinkedIn about a recent article by Baldwin, published in Emergency Medicine News, adding:
”One of the most important moments in stroke prevention may occur in the Emergency Department.
Atrial fibrillation is increasingly encountered during acute care encounters, but initiating anticoagulation is often only the beginning of the challenge.
In real-world practice, the long-term success of anticoagulation frequently depends on what happens after discharge:
- patient understanding
- renal function follow-up
- medication affordability/access
- transitions of care
- peri-procedural planning
- coordination between clinicians
Underdosing DOACs ‘for safety’ when criteria are not met is another important issue that deserves continued attention, as inappropriate dose reduction may reduce efficacy without meaningfully improving outcomes.
Anticoagulation management is rarely just about selecting a drug.
It is about building a safe, understandable, sustainable plan for the patient.
That is where interdisciplinary care—including physicians, pharmacists, nurses, and patients themselves—can make a tremendous difference.”
Quoting Emergency Medicine News’s post:
”Atrial fibrillation is rising in the ED and early anticoagulation is one of the most impactful ways to prevent stroke. Current guidelines emphasize CHA₂DS₂‑VASc–based decisions, DOACs over warfarin, and correcting bleeding risks rather than withholding therapy.
Avoid underdosing (it raises stroke risk nearly 5 times), ensure patients understand their regimen, and remember: all cardioversion patients need at least 4 weeks of anticoagulation, regardless of method or timing.
ED clinicians are uniquely positioned to start stroke prevention at the moment it matters most.”
Title: Anticoagulation Strategies for Stroke Prevention in Atrial Fibrillation
Authors: Baldwin, Kendall PharmD Candidate, Hile, Kaitlin PharmD, BCCP, Hile, Garrett PharmD, BCEMP, BCCCP, Howington, Gavin T. PharmD, BCCCP, BCEMP

Stay updated on all scientific advances with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers